Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms
Lü Jin, Wei Zhang, Ming-Yu Yao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 47
mTOR in programmed cell death and its therapeutic implications
Yawen Xie, Xianli Lei, Guoyu Zhao, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 66-81
Open Access | Times Cited: 36
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo
Yuanyuan Mi, Yu Ji, Lifeng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
Peng He, Qiang Dai, Xiaojun Wu
Environmental Research (2023) Vol. 229, pp. 115672-115672
Closed Access | Times Cited: 12
Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth
Lü Jin, Jin Zhu, Linya Yao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 10
From Therapy Resistance to Targeted Therapies in Prostate Cancer
Filipa Moreira‐Silva, Rui Henrique, Cármen Jerónimo
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Advances in the regulatory mechanisms of mTOR in necroptosis
Yawen Xie, Guoyu Zhao, Xianli Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer
Xiaojun Li, Linya Yao, Tao Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 5
KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo
Feng Cheng, Yufei Tang, Yang Cao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1
PI3Kα inhibitor GNE-493 triggers antitumor immunity in murine lung cancer by inducing immunogenic cell death and activating T cells
Xiaomin Xue, Guanzhi Ye, Long Zhang, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111747-111747
Closed Access
Page 1

Scroll to top